Source: Annual Congress 2003 - Cystic fibrosis: new genes, new controversies
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Chadelat, H. Corvol, C. Flamant, M. Roussey, F. Bremont, A. Flahault, M. C. Miesch, A. Clement, A. Henrion-Caude (Paris, Rennes, Toulouse, France). Interleukin-1 receptor antagonist gene polymorphism and Pseudomonas aeruginosa chronic infection in children with cystic fibrosis. Eur Respir J 2003; 22: Suppl. 45, 1131

Member's Comments

No comment yet.

Related content which might interest you: Polymorphisms of the IL-10 gene and pseudomonas aeruginosa infection in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 717s Year: 2006 Interleukin-6 gene variants are associated with early Pseudomonas infection in cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 727s Year: 2005 Susceptibility to chronic bacterial purulent rhinosinusitis is associated with the combination of interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphic alleles Source: Eur Respir J 2005; 26: Suppl. 49, 406s Year: 2005 Interleukin-1b and interleukin-1 receptor antagonist gene polymorphisms in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 136s Year: 2004 The chemokine CCL18 characterises Pseudomonas infections in cystic fibrosis lung disease Source: Eur Respir J 2014; 44: 1608-1615 Year: 2014 Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis Source: Eur Respir J 2007; 30: 286-292 Year: 2007 Association of IL-8 A-251T polymorphism with Pseudomonas aeruginosa infection and lung function decline in children with CF Source: Eur Respir J 2005; 26: Suppl. 49, 726s Year: 2005 Chronic Pseudomonas aeruginosa lung infection, but not CFTR modulator therapy affects circulating regulatory T cells in an adult population with cystic fibrosis Source: Virtual Congress 2021 – Adult cystic fibrosis Year: 2021 Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa Source: Eur Respir J 2003; 22: 503-506 Year: 2003 Single nucleotide polymorphisms in genes of the innate immunity in cystic fibrosis patients: correlation with lung function and pseudomonas aeruginosa (P.a.) colonisation Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008 Chronic but not intermittent infection with Pseudomonas aeruginosa is associated with global changes of the lung microbiome in cystic fibrosis Source: Eur Respir J, 50 (4) 1701086; 10.1183/13993003.01086-2017 Year: 2017 Antiapoptotic and proinflammatory function of toll-like receptor 2 in acute C. pneumoniae infection of COPD lung tissue Source: Eur Respir J 2006; 28: Suppl. 50, 575s Year: 2006 Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 379s Year: 2002 Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients Source: Eur Respir J 2008; 31: 822-829 Year: 2008 Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis Source: Virtual Congress 2021 – Back to infection basics Year: 2021 Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis Source: Eur Respir J 2005; 26: 651-656 Year: 2005 TNF and LTA gene polymorphisms in cystic fibrosis patients with Burkholderia cepacia complex (Bcc) Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis Year: 2021 Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre Source: Eur Respir J 2006; 27: 937-943 Year: 2006 Toll-like receptor polymorphisms associated with progression of Mycobacterium tuberculosis infection to pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 142s Year: 2006